USGI’s incisionless surgery platform, the EndoSurgical Operating System (EOS), is designed to address a wide range of surgical indications. Surgeons and gastroenterologists currently use the EOS to perform
This is a continuance of the licensing partnership arGentis has with the Southern College of Optometry and becomes the third prospective therapy for dry eye syndrome (DES) that
Located at 2/F of Building A, Jinxiongda Technology Park, Guanlan, Bao’an District, Shenzhen, China, the new 18,000 square foot facility currently houses a staff of twenty-five employees. SunTech
The Company has initiated an executive search for this position and, on interim basis, Christopher Reinhard, the company’s executive chairman will assume executive responsibilities for the operations of
Merck plans to conduct a number of clinical studies in hypertensive patients involving single and multiple ascending dosing, prior to the selection of a compound to be advanced
Ricardo Diaz will head Chiltern’s new office as country manager. Mr Diaz has over 10 years experience in clinical research and holds a master’s degree in Pharmacology, a
The trial enrolled a total of 48 patients of which 37 have reached the final 12 month follow up evaluation. The data for these first 37 patients indicate
In preparation for conducting a thorough QT study (TQT), Repros has completed a pilot trial dosing healthy female volunteers for seven days with Proellex 200mg. Formal QT studies
The study known as VS411-C201 is a five-arm, dose-ranging, proof of principle study. Investigators in four countries, Italy, Russia, Uganda, and Argentina, will enroll 60 patients into five
In extensive preclinical studies, VEL-0230 proved to be a powerful anti-inflammatory agent that also stimulates bone formation and inhibits bone loss. Taken together, these characteristics strongly suggest this
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.